How long does BPC-157 take to work?
Some patients report noticing changes within 2-4 weeks, though individual responses vary. Consistent use for 8-12 weeks is typically recommended.
BPC-157 — Healing Support Peptide at RegenesisMD
BPC-157 (Body Protection Compound-157) is a synthetic peptide sequence derived from a protective protein found in human gastric juice. It is prescribed as a compounded medication for off-label uses at RegenesisMD. Typical program: 4–8 weeks at $250–$500 total. Individual results vary.
FDA status
BPC-157 is a compounded medication that is not FDA-approved for the uses described on this page. The FDA has not evaluated the safety or effectiveness of compounded BPC-157 for these indications. In recent years the FDA has placed BPC-157 in a category that is generally not eligible for compounding by 503A pharmacies. Whether RegenesisMD can prescribe BPC-157 for any individual patient depends on current FDA guidance and the determination of a licensed compounding pharmacy at the time of prescription. Your provider will discuss the most current regulatory status during your consultation.
What it may support
- May support tissue healing.
- May help reduce inflammation.
- May support gut health.
- May promote joint recovery.
- May support muscle repair.
Mechanisms studied in BPC-157 research include angiogenesis pathways, growth factor expression related to tissue repair, inflammatory response modulation, and GI tract cellular protection. These mechanisms have been demonstrated primarily in laboratory and animal studies. Clinical efficacy in humans is still being researched.
Who it may be appropriate for
- Chronic soft tissue discomfort (tendons, ligaments, muscles).
- Recovery goals after orthopedic procedures.
- Digestive health concerns.
- Athletic performance and recovery goals.
- Joint discomfort from overuse.
- Interest in regenerative medicine approaches.
BPC-157 is a compounded medication prescribed off-label. A thorough medical evaluation by a RegenesisMD provider is required to determine if this treatment is appropriate for your specific health needs and goals.
Protocol
- Dosing individualized by a RegenesisMD provider based on your medical history and goals.
- Administration: subcutaneous injection (training provided).
- Duration: typically 4–8 weeks, adjusted based on response.
- Monitoring: regular follow-ups to assess response and adjust protocol.
Frequently Asked Questions
Is BPC-157 safe?
Research suggests BPC-157 has a favorable safety profile in clinical studies, though individual responses may vary. Your provider will discuss potential risks during your consultation.
How is BPC-157 administered?
BPC-157 can be administered via subcutaneous injection or orally, depending on the treatment goal determined during consultation.
Medical disclaimer
This page is educational and does not constitute medical advice. BPC-157 is a compounded peptide that is not FDA-approved for the indications described and is not marketed to treat, cure, prevent, or diagnose any disease. Outcomes are not guaranteed and individual results vary. Eligibility is reviewed individually with your provider.